| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/23/2006 | US20060063835 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/23/2006 | US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren |
| 03/23/2006 | US20060063813 Organic compounds |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063801 Anticancer therapeutics; 3-(7-Methoxy-4-oxo-4H-1-benzopyran-2-yl)-1-phenyl-1H-1,4-dihydroquinolin-4-one |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063768 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063762 Indole indazole and benzazole derivative |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | US20060063717 Novel inhibitor of beta amyloid cleavage |
| 03/23/2006 | US20060063235 DNA encoding the human serine protease C-E |
| 03/23/2006 | US20060063203 Vascular endothelial cell growth factor variants and uses thereof |
| 03/23/2006 | US20060062856 Controlled release galantamine composition |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | CA2580692A1 Use of glutamic acid or salts thereof in preventing or improving functional digestive disorder |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/23/2006 | CA2580236A1 Purinenucleoside derivative modified in 8-position and medical use thereof |
| 03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | CA2579490A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/23/2006 | CA2575788A1 Combination of pkc activators and pkc inhibitors for alzheimer's diseasetreatment and cognitive enhancement |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637539A1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 03/22/2006 | EP1637528A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637519A1 Crystalline forms of the sodium salt of 5-chloro-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamide |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1637517A1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637156A1 Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
| 03/22/2006 | EP1637154A2 High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1637132A1 External preparation for athlete´s foot treatment |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1635848A1 Methods of managing the symptoms of premenstrual syndrome |
| 03/22/2006 | EP1635837A1 (3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer |
| 03/22/2006 | EP1635819A1 Staurosporine derivatives for hypereosinophilic syndrome |
| 03/22/2006 | EP1635806A2 Method for treating alcoholic hepatitis |
| 03/22/2006 | EP1635799A2 Pharmaceutical formulations of amyloid inhibiting compounds |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 03/22/2006 | EP1461436A4 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 03/22/2006 | EP1458377B1 Tegaserod pharmaceutical compositions |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1404301A4 Stable controlled release pharmaceutical compositions containing pravastatin |
| 03/22/2006 | EP1377586B1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 03/22/2006 | EP1377294B1 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1328253B1 Administration of a thiol-based chemoprotectant compound |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1313463B1 Fatty acid analogues for the treatment of cancer |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1248618B1 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl |
| 03/22/2006 | EP1221963A4 Methods of inhibiting osteoclastogenesis |
| 03/22/2006 | EP1221847A4 Methods of enhancing chemotherapy |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1212089B1 Synergistic combination of roflumilast and salmeterol |
| 03/22/2006 | EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 03/22/2006 | EP1179008B1 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | EP1093818B1 Powdery preparation for mucosal administration containing polymeric medicine |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0934086B1 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1750870A Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750837A Superoxide anion decomposing agent |
| 03/22/2006 | CN1750832A Blood-vessel-growth promoter |
| 03/22/2006 | CN1750831A Therapeutic agent for hemorrhoidal disease |
| 03/22/2006 | CN1750762A Composition containing isoflavone of high purity at high concentration and process for producing the same |
| 03/22/2006 | CN1748785A Water solution preparation of reducing type glutathione, its preparing method and use |
| 03/22/2006 | CN1748774A Brain tonifying preparation and new preparing method |
| 03/22/2006 | CN1748773A Shengji fresh-water turtle shell preparation and new preparing method |
| 03/22/2006 | CN1748767A Lupus preparation and new preparing method |
| 03/22/2006 | CN1748753A Waist pain preparation and new preparing method |
| 03/22/2006 | CN1748748A Little leaf deervetch herb preparation for pregnant woman and new preparing method |
| 03/22/2006 | CN1748738A Chinese medicine cinnamon twig and poria dripping pill and its preparing method |
| 03/22/2006 | CN1748737A Xiaojin preparation and new preparing method |
| 03/22/2006 | CN1748732A Pill for sweating due to debility |
| 03/22/2006 | CN1748720A Medicine for anti-fatigue and its preparing method |